Valeant (VRX), DepoMed (DEPO) Sue Watson (WPI) Over Generic Glumetza
Tweet
Share
E-mail
Bloomberg reporting Valent Pharma (NYSE: VRX) and DepoMed (Nasdaq: DEPO) have sued Watson (NYSE: WPI), challenging the company's generic glumetza product.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quantum Cyber rejects short-seller's offer to halt reports if lawsuit dropped
- AEVEX wins $41M U.S. government contract for one-way attack systems
- Murphy USA tests automated White Castle food kiosks in select stores
Create E-mail Alert Related Categories
Corporate News, LitigationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
